Globus Medical (GMED) reported Q4 non-GAAP earnings late Tuesday of $1.28 per diluted share, up from $0.84 a year earlier.

Analysts polled by FactSet expected $1.13.

Net sales for the quarter ended Dec. 31 were $826.4 million, up from $657.3 million a year earlier.

Analysts surveyed by FactSet expected $801.7 million.

The company updated its full-year 2026 adjusted EPS guidance to $4.40 to $4.50 from the prior range of $4.30 to $4.40.

Analysts expect $4.17.

Globus Medical maintained its 2026 revenue guidance of $3.18 to $3.22 billion.

Analysts expect $3.16 billion.